Alpa Laboratories (NSE:ALPA) Beta: 2.2622 (As of Jun. 24, 2026)


NSE:ALPA Alpa Laboratories Ltd NSE:ALPA
76 GF Score
Price ₹67.66
GF Value ₹92.72
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Alpa Laboratories Beta?

Alpa Laboratories NSE:ALPA +0.12% 76 Beta is 2.2622 as of Jun. 24, 2026. GuruFocus rates NSE:ALPA with a GF Score™ of 76/100 and a GF Value™ of ₹92.72 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), Alpa Laboratories's Beta is 2.2622.


Alpa Laboratories  (NSE:ALPA) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Alpa Laboratories Beta Related Terms


Alpa Laboratories Beta Historical Data

* Premium members only.

The historical data trend for Alpa Laboratories's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpa Laboratories Beta Chart

Alpa Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.14 1.10 0.70 1.38 2.04

Alpa Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 1.33 1.40 1.79 2.04

NSE:ALPA vs ZTS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpa Laboratories Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's Beta distribution charts can be found below:

* The bar in red indicates where Alpa Laboratories's Beta falls into.


NSE:ALPA
76GF Score
Alpa Laboratories Ltd NSE:ALPA
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpa Laboratories Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.2622 mean?
Alpa Laboratories (NSE:ALPA) has a Beta of 2.2622 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Alpa Laboratories and its competitors.
Is Alpa Laboratories' Beta too high?
Alpa Laboratories' current Beta is 2.2622. Overall, Alpa Laboratories has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alpa Laboratories' Beta compare to ZTS?
Alpa Laboratories' Beta of 2.2622 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Alpa Laboratories and its competitors. Alpa Laboratories's current Beta is 2.2622. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alpa Laboratories (NSE:ALPA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹92.72, compared to a current price of ₹67.66 — trading 27% below its estimated fair value. The current Beta is 2.2622. Alpa Laboratories' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Alpa Laboratories (NSE:ALPA), the current Beta is 2.2622 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alpa Laboratories (NSE:ALPA) Overvalued in 2026?

Based on GuruFocus' analysis, Alpa Laboratories stock appears to be undervalued. The current stock price of ₹67.66 is trading 27% below its estimated GF Value™ of ₹92.72. GuruFocus considers Alpa Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:ALPA:

  • Beta: 2.2622
  • GF Value™: ₹92.72 vs. price of ₹67.66 (27% below fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the NSE:ALPA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alpa Laboratories Business Description

Other Exchanges 532878:India
Address 33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the drug and chemical business segment. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.
76GF Score

Get the complete analysis for NSE:ALPA

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹67.66
Price
₹92.72
GF Value